Celgene Corporation - Net Worth and Insider Trading
Celgene Corporation Net Worth
The estimated net worth of Celgene Corporation is at least $91 Million dollars as of 2024-09-13. Celgene Corporation is the 2201 Interest of corporation controlled by you of JW (Cayman) Therapeutics Co Ltd and owns about 70,231,140 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) stock worth over $91 Million. Details can be seen in Celgene Corporation's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Celgene Corporation has not made any transactions after 2021-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Celgene Corporation
Celgene Corporation Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Celgene Corporation owns 1 companies in total, including JW (Cayman) Therapeutics Co Ltd (HKSE:02126) .
Click here to see the complete history of Celgene Corporation’s form 4 insider trades.
Insider Ownership Summary of Celgene Corporation
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
HKSE:02126 | JW (Cayman) Therapeutics Co Ltd | 2021-02-08 | 2201 Interest of corporation controlled by you |
Celgene Corporation Latest Holdings Summary
Celgene Corporation currently owns a total of 1 stock. Celgene Corporation owns 70,231,140 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) as of February 8, 2021, with a value of $91 Million.
Latest Holdings of Celgene Corporation
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
HKSE:02126 | JW (Cayman) Therapeutics Co Ltd | 2021-02-08 | 70,231,140 | 1.30 | 91,300,482 |
Holding Weightings of Celgene Corporation
Celgene Corporation Form 4 Trading Tracker
According to the SEC Form 4 filings, Celgene Corporation has made a total of 1 transactions in JW (Cayman) Therapeutics Co Ltd (HKSE:02126) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in JW (Cayman) Therapeutics Co Ltd is the sale of 0 shares on February 8, 2021, which brought Celgene Corporation around $0.
Insider Trading History of Celgene Corporation
- 1
Celgene Corporation Trading Performance
Celgene Corporation Ownership Network
Celgene Corporation Owned Company Details
What does JW (Cayman) Therapeutics Co Ltd do?
Who are the key executives at JW (Cayman) Therapeutics Co Ltd?
Celgene Corporation is the 2201 Interest of corporation controlled by you of JW (Cayman) Therapeutics Co Ltd. Other key executives at JW (Cayman) Therapeutics Co Ltd include 2202 Interest of your spouse Li Dan , 2201 Interest of corporation controlled by you Li Yiping James , and 2501 Other Syracuse Biopharma (Cayman) II, Ltd. .
JW (Cayman) Therapeutics Co Ltd (HKSE:02126) Insider Trades Summary
Over the past 18 months, Celgene Corporation made no insider transaction in JW (Cayman) Therapeutics Co Ltd (HKSE:02126). Other recent insider transactions involving JW (Cayman) Therapeutics Co Ltd (HKSE:02126) include a net sale of 0 shares made by Li Dan , and a net sale of 0 shares made by Li Yiping James .
In summary, during the past 3 months, insiders sold 0 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of JW (Cayman) Therapeutics Co Ltd (HKSE:02126) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
JW (Cayman) Therapeutics Co Ltd (HKSE:02126)'s detailed insider trading history can be found in Insider Trading Tracker table.
JW (Cayman) Therapeutics Co Ltd Insider Transactions
Celgene Corporation Mailing Address
Above is the net worth, insider trading, and ownership report for Celgene Corporation. Currently GuruFocus does not have mailing address information for Celgene Corporation.